🟢 20/20 Biolabs is trading 7.11% up in after-hours trading with no confirmed catalyst

20/20 Biolabs is trading at $0.66, +7.11% in after-hours trading, with no confirmed August 31 company-specific announcement or late-breaking filing explaining the move.

• The stock closed at $0.62 on August 31, 2026.
• Investor attention may remain focused on the September 2 webinar covering OneTest™ revenue and commercial expansion, rescheduled to 2:00 p.m. Eastern time.
• The move remains an unclear catalyst pending further disclosure.